In line with molecular docking, these two triterpenoids were also among the strongest binding affinities (< − 9.78 kcal/mol) to blood pressure modulate targets AT1R and HSD11B1, emphasizing them as promising pharmacologically contributing drug candidates for mitigating not only DS but also MetS associated hypertension. This evidence concerns the gene AGTR1 and metabolic syndrome.